Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells.
about
CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia.A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL.Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agentsFludarabine- (C2-methylhydroxyphosphoramide)- [anti-IGF-1R]: Synthesis and Selectively "Targeted"Anti-Neoplastic Cytotoxicity against Pulmonary Adenocarcinoma (A549)Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathwaysBendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myelomaIbrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia.Idelalisib and bendamustine combination is synergistic and increases DNA damage response in chronic lymphocytic leukemia cells.Reevaluation of ATR signaling in primary resting chronic lymphocytic leukemia cells: evidence for pro-survival or pro-apoptotic function.
P2860
Q30383411-9DA67A8D-985A-4D29-B446-BAE8743C2B2FQ33591830-FFA02288-9003-419D-9F8C-5CC099932501Q36293814-165D23D5-5AE7-4EFD-ADDD-86863ECDEBDCQ36311218-2141D755-1B43-45A9-AFD1-23C7B1FFE001Q36689108-056672A3-7E1F-47DD-BB5D-3A6E104F4C9BQ37313790-365A50FF-8584-4462-91C6-BE793D528296Q37688589-3092C649-51D1-486D-94EA-F5405973ACE7Q37725415-67A6E734-548E-4AC3-8145-A5C6A75A7C76Q41344084-764B9512-1084-4AF8-B2C6-9058630F7C6C
P2860
Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evaluation of bendamustine in ...... ic lymphocytic leukemia cells.
@ast
Evaluation of bendamustine in ...... ic lymphocytic leukemia cells.
@en
type
label
Evaluation of bendamustine in ...... ic lymphocytic leukemia cells.
@ast
Evaluation of bendamustine in ...... ic lymphocytic leukemia cells.
@en
prefLabel
Evaluation of bendamustine in ...... ic lymphocytic leukemia cells.
@ast
Evaluation of bendamustine in ...... ic lymphocytic leukemia cells.
@en
P2093
P2860
P1433
P1476
Evaluation of bendamustine in ...... ic lymphocytic leukemia cells.
@en
P2093
Amal A El-Mabhouh
Elizabeth J Shpall
Mary L Ayres
Varsha Gandhi
Veerabhadran Baladandayuthapani
P2860
P304
P356
10.1182/BLOOD-2013-12-541433
P407
P577
2014-04-18T00:00:00Z